Isfahan Milad Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02447211
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Head, Department of Radiation Oncology,Isfahan Milad Hospital, Isfahan,Iran